Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy.
All Authors:
Authors
Kesselheim AS, Avorn J.
Author Profiles:
Persons
Publish Date:
Date
Journal:
Venue / Journal
JAMA
Additional Journal Information
316(22):2357-2358